Opal Wealth Advisors’s Boston Scientific BSX Stock Holding History

Opal Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,718	Closed	-$108K	–	285
2026 Q1	$108K	Buy	+1,718	New	+$137K	0.02%	274
2025 Q3	–	Sell	-1,444	Closed	-$155K	–	249
2025 Q2	$155K	Sell	1,444 -46	-3%	-$4.65K	0.04%	219
2025 Q1	$150K	Buy	+1,490	New	+$150K	0.05%	215
2024 Q3	–	Sell	-1,422	Closed	-$110K	–	325
2024 Q2	$110K	Buy	+1,422	New	+$104K	0.04%	254

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Opal Wealth Advisors's BSX Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 1,718 shares — an estimated $108K sold.

Opal Wealth Advisors first reported a position in BSX in Q2 2024 and held it in 4 quarters. The position peaked at $155K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Opal Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Opal Wealth Advisors sold 1,718 Boston Scientific shares in Q2 2026, an estimated $108K.
Opal Wealth Advisors first reported a position in Boston Scientific in Q2 2024 and held it in 4 quarters.
Opal Wealth Advisors's Boston Scientific position peaked at $155K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.